Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

Weight loss drug semaglutide reduces risk of adverse cardiovascular events by 20% among overweight, obese patients

Weekly subcutaneous treatments of semaglutide, originally developed to treat diabetes, are sold and marketed under the brand name Wegovy.

August 8, 2023
insurance

Expanding Medicaid linked to better care for heart patients

New research, based on data from approximately 143 million patients, focused on prescriptions for heart failure, atrial fibrillation and other significant cardiac conditions. 

August 3, 2023
Mayo Clinic was listed the No. 3 top cardiovascular hospital in the nation by U.S. News and World Report.

The 25 best U.S. cardiology hospitals ranked

U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals. 

August 2, 2023
the words "FDA recall" on a board

Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”

July 18, 2023
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 

July 11, 2023
Cardiology cardiologist compensation salary survey nurses service line managers billing

Salaries and job satisfaction in cardiology: 8 takeaways from a new survey of cardiologists and their colleagues

The 2023 Cardiovascular Business Salary and Job Satisfaction Report is here! We surveyed cardiologists, interventional cardiologists, nurses, service line mangers, coders and others in the industry about several topics, including compensation, burnout, EHRs and much more.

July 10, 2023
The Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and Heart Rhythm Society (HRS) have asked the U.S. Centers for Medicare and Medicaid Services (CMS) to clarify a key detail related to the national coverage determination (NCD) for percutaneous left atrial appendage closure (LAAC).

Interventional cardiologists, electrophysiologists ask CMS to clarify policy after unexpected denials

Three cardiology societies have reached out to CMS with questions about how MACs are interpreting a policy related to shared decision-making. 

July 6, 2023
Roberto Lang, MD, explained the AI advances in echocardiography that will make it a requirement to have in the coming years at ASE 2023. #ASE #AIhealthcare #ASE2023

Echo labs not using AI will be left behind

Echocardiography expert Roberto Lang, MD, says artificial intelligence will be so important to cardiac ultrasound in the near future that echo labs not using it will be inefficient and less accurate than labs that do use it.

July 3, 2023
Displaying 73 - 80 of 579

Around the web

Cardiovascular Business
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine

Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.

Cardiovascular Business
Cardiologists, thoracic surgeons applaud FTC’s ban of most noncompete clauses

The Society for Cardiovascular Angiography & Interventions and Society of Thoracic Surgeons have both shared statements in support of the ban, which is already being challenged in court. The American Hospital Association, meanwhile, opposes the policy shift, saying it “errs by seeking to create a one-size-fits-all rule”

Cardiovascular Business
Why the business side of cardiology was a key focus at ACC.24

Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup